Angiotensin-Receptor Blockers (ARBs) and risk of Alzheimer ´s Disease: A meta-analysis.

CONCLUSION: ARB use may reduce the risk of incident AD. This association does not imply causation and further research is required to clarify potential mechanisms. PMID: 32003701 [PubMed - as supplied by publisher]
Source: Current Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Tags: Curr Clin Pharmacol Source Type: research